Navigation Links
Gene-Edited Chicken Cells Resist Avian Influenza Virus in the Lab
Date:6/6/2019

Cobb-Vantress, Inc. / Siloam Springs, Arkansas, USA: In newly released research, scientists from The Roslin Institute have prevented the avian influenza virus from replicating in lab-grown chicken cells, suggesting that it may one day be possible to produce chickens that are resistant to the disease. The study was funded by Biotechnology and Biological Sciences Research Council with additional funding from Cobb-Vantress. The Roslin Institute — a world-leading center for animal science research — conducted the study last year and the results were published in eLife this week.

To inhibit the avian influenza virus from replicating, the research team used gene-editing techniques to delete a section of chicken DNA inside lab-grown cells. Researchers targeted a specific molecule inside chicken cells called ANP32A, which the influenza virus takes over to help replicate itself. After removing the section of DNA responsible for producing ANP32A, the virus was no longer able to grow inside cells with the genetic change.

Researchers at The Roslin Institute, in collaboration with experts from Cambridge University, previously produced chickens that did not transmit avian influenza to other chickens following infection using genetic modification techniques. This new approach is unique because it does not involve introducing new genetic material into the bird’s DNA.

“This is an important advance that suggests we may be able to use gene-editing techniques to produce chickens that are resistant to avian influenza,” said Helen Sang, professor at The Roslin Institute. “We haven’t produced any birds yet and we need to check if the DNA change has any other effects on the bird cells before we can take this next step.”

Avian influenza is a global threat to poultry production, accounting for the loss of millions of chickens when an outbreak occurs. Severe strains have the potential to kill entire flocks and, in rare instances, certain strains of the virus can infect people, causing serious illness. Efforts to control the spread of the disease are urgently needed.

“Avian influenza resistance in broiler production is of global significance,” said Rachel Hawken, senior director of genomics and quantitative genetics at Cobb-Vantress. “This research is an important step toward that goal. It’s exciting for Cobb to be a part of exploring new technologies that could be used to advance poultry breeding in the future.”

Genomic research is nothing new for Cobb, which has invested in the field for many years to select superior breeding stock using individual DNA information (not DNA alterations) and individual performance measures to calculate a measure of genetic merit. The company also participates in the investigation of many new technologies as they become available to improve their ability to produce healthy, high-performing breeding stock.

“Genomics has allowed us to incorporate new programs into our research, opening new unexplored opportunities to improve our broilers for the future markets,” said Hawken. “We’re committed to serving our customers using innovative research and technology to make protein healthy and affordable to everyone.”

To read the full study in eLife, visit https://elifesciences.org/articles/45066.

ABOUT COBB-VANTRESS, INC.
Cobb-Vantress, Inc. makes quality protein accessible, healthy and affordable worldwide. Our research and technology innovates the global poultry industry. With headquarters in Siloam Springs, Arkansas, we are the world’s oldest pedigree broiler breeder. We distribute poultry to more than 120 countries. Find more at cobb-vantress.com.

Distributed by HLK
Jennifer Elston | jelston@hlkagency.com | 816.217.8410

Read the full story at https://www.prweb.com/releases/gene_edited_chicken_cells_resist_avian_influenza_virus_in_the_lab/prweb16360514.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Priming Cardiac Progenitor Cells Accelerates Cardiomyocyte Maturation
2. Data Published in Nature Methods Demonstrate Breakthrough Ability to Accurately Detect Somatic Single Nucleotide Variations in Single Cells
3. Vanrx Pharmasystems comes to Interphex 2017 with growing momentum for its Aseptic Filling Workcells
4. Wide Distribution of Initial Oxygen Saturation Levels in Red Cells Stored for Transfusion, May Significantly Influence Cell Quality and Therapeutic Efficacy
5. ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens
6. New Study Shows Ketamine May Regenerate Brain Cells, Relieving Depression with Lasting Benefit
7. Researchers Show Novel Material Encapsulated Human Islet Cells Can Halt Type 1 Diabetes for Six Months
8. Global Stem Cells Market 2015-2021: Increasing Use of Biomarkers & Growth in Biopsy Market
9. Scientists Gain Better Understanding of How Dormant Circulating Tumor Cells in Breast Cancer Become Metastatic in the Brain
10. CTI BioPharma Announces Presentation of Preclinical Data Demonstrating Potential Synergistic Combination of Pacritinib and an EGFR Inhibitor in Targeting Brain Tumor Initiating Cells
11. Stem Cells Market Size To Reach $170.1 Billion By 2020: Grand View Research, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2019)... ... September 12, 2019 , ... iPatientCare, a ... practice management, and patient engagement solutions, announced today the participation of Amazon ... (NUCON) 2019 . The annual conference features informative sessions about upcoming enhancements, ...
(Date:9/11/2019)... ... September 11, 2019 , ... Pressley Ridge will host a ... for the Deaf on September 20 at 1 p.m. on their Marshall Avenue campus ... for many years, this is the first time they have a permanent—and state-of-the-art—home. Designed ...
(Date:9/11/2019)... TORONTO (PRWEB) , ... September 11, 2019 , ... ... cannabis is undergoing a period of rediscovery and attraction from big pharma, nutraceutical ... the American population, and North American use rates are expected to rise as ...
Breaking Medicine Technology:
(Date:9/14/2019)... CULVER CITY, Calif. (PRWEB) , ... ... ... World Molecular Imaging Society (WMIS) showcased several first-in-human studies on the detection ... in Montreal. Highlighting two examples of these ground-breaking studies were noninvasive detection ...
(Date:9/12/2019)... ... September 12, 2019 , ... ... local and national scale in two recent and well-renowned listing publications, the Inc. ... held businesses for the 2019 year. , Dr. Jeffrey Donaldson, CEO and ...
(Date:9/11/2019)... LONDON (PRWEB) , ... September 11, 2019 , ... ... is ever-evolving, although many industries have struggled to solve injury risks which lead ... the organisation, the wearable technology solution developed by the team at Soter ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... (UMA) and an accredited continuing medical education (CME) provider, is the official accreditor ... Global reviewed presentations, vetted speakers, and screened topics, as it has done for ...
(Date:9/11/2019)... ... 11, 2019 , ... GRM Information Management, a leading provider ... Information Conference in Chicago, Illinois September 14 to 18. , AHIMA conference ... healthcare information management solutions . , Built around their robust, cloud-based content ...
Breaking Medicine News(10 mins):